Profile
| Role | Director |
|---|---|
| Notability | 10/100 |
Board memberships
- Y-mAbs Therapeutics, Inc.
Updated Jul 16, 2026
GILL DAVID N is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
| Role | Director |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-20 | EOLS | Evolus, Inc. | A — Grant or award | 45.6K | $0.00 | |
| 2025-09-16 | YMAB | Y-mAbs Therapeutics, Inc. | D — Derivative transaction | 25.1K | — | |
| 2025-09-16 | YMAB | Y-mAbs Therapeutics, Inc. | D — Derivative transaction | 5.8K | $8.60 | $50K |
| 2025-06-30 | YMAB | Y-mAbs Therapeutics, Inc. | A — Grant or award | 25.1K | $0.00 |
GILL DAVID N is a corporate insider — currently tracked as Director. InsiderAlpha tracks every SEC Form 4 filing in real time.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live GILL DAVID N profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.